DC11097 |
ADX-102 (Reproxalap;NS-2)
Featured
|
ADX-102 (Reproxalap, NS-2) is a novel small molecule immunomodulator that covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal, which have been shown to mediate inflammatory pain; DX-102 is a promising agent for the treatment of dry eye disease. |
|
DCAPI1467 |
Alcaftadine |
Alcaftadine |
|
DC9632 |
BAY 61-3606 (dihydrochloride)
Featured
|
BAY 61-3606 2Hcl is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (Ki= 7.5 nM) with no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src.
|
|
DC10660 |
BAY 61-3606 free base
Featured
|
BAY 61-3606 is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (Ki= 7.5 nM) with no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src.
|
|
DC9154 |
Cetirizine 2HCl |
Cetirizine 2Hcl, a second-generation antihistamine, is a major metabolite of hydroxyzine, and a racemic selective H1 receptor inverse agonist used in the treatment of allergies, hay fever, angioedema, and urticaria. |
|
DC9104 |
Loratadine |
Loratadine(SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 μM. |
|
DCAPI1355 |
Loteprednol etabonate |
Loteprednol etabonate |
|
DC3160 |
Montelukast Sodium
Featured
|
Montelukast belongs to a group of medications known as leukotriene receptor antagonists. |
|
DC7472 |
Nedocromil |
Nedocromil is an inhaled anti-inflammatory agent for the preventive management of asthma. |
|
DCAPI1388 |
Suplatast tosylate |
Suplatast tosylate |
|
DC6400 |
Tranilast (SB 252218)
Featured
|
Tranilast (SB 252218) |
|